These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 19657752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
    Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P.
    J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ErbB-2 expression and hormone receptor status in areas of transition from in situ to invasive ductal breast carcinoma].
    Peres RM, Derchain SF, Heinrich JK, Serra KP, Pinto GA, Soares FA, Sarian LO.
    Rev Bras Ginecol Obstet; 2009 Sep; 31(9):461-7. PubMed ID: 19876578
    [Abstract] [Full Text] [Related]

  • 10. Down regulation of bcl2 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors.
    Park SH, Kim H, Song BJ.
    Pathol Oncol Res; 2002 Sep; 8(1):26-30. PubMed ID: 11994759
    [Abstract] [Full Text] [Related]

  • 11. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y.
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.
    Baqai T, Shousha S.
    Histopathology; 2003 May; 42(5):440-7. PubMed ID: 12713620
    [Abstract] [Full Text] [Related]

  • 16. Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma.
    Matsuo K, Fukutomi T, Akashi-Tanaka S, Hasegawa T, Tsuda H.
    Breast Cancer; 2002 May; 9(2):127-33. PubMed ID: 12016392
    [Abstract] [Full Text] [Related]

  • 17. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, Ricci L, Fan F, Tawfik O, Marks JR, Knapp JR, Yeh HW, Thomas P, Carrasco DR, Fields TA, Godwin AK, Behbod F.
    Breast Cancer Res; 2015 Sep 17; 17():128. PubMed ID: 26384318
    [Abstract] [Full Text] [Related]

  • 18. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M, Xu SP, Ao QL.
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr 17; 42(4):257-61. PubMed ID: 23928534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.